Skip to main content

Advertisement

Table 2 Potential biomarkers-related to hyperuricemia. Samples were harvested on 7th day

From: Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats

NO Inoziation Rt (min) m/z Molecular Formula Compound Trend
1 ESI- 4.4668 495.6301 C24H50NO7P LPC(16:0)
2 ESI- 5.0988 523.6832 C26H54NO7P LPC(0:0/18:0)
3 ESI- 8.9063 978.5961 C65H100O6 TG(18:1/22:6/22:5)
4 ESI+ 9.8594 785.5935 C44H84NO8P PC(18:0/18:2)
5 ESI+ 5.8419 521.3481 C26H52NO7P LPC(18:1)
6 ESI+ 8.5336 531.2757 C27H48NO7P LPE(22:4/0:0)
7 ESI+ 7.7872 691.5152 C37H74NO8P PE(14:0/18:0)
8 ESI+ 8.5361 575.7578 C30H58NO7P LPC(22:2)
9 ESI+ 6.7964 607.4577 C32H66NO7P LPC(24:0)
10 ESI+ 7.4282 677.4996 C36H72NO8P PC(14:0/14:0)
11 ESI+ 8.727 806.1031 C46H80NO8P PC(16:0/22:6)
12 ESI+ 7.3395 663.4839 C35H70NO8P PE(16:0/14:0)
13 ESI+ 7.9401 685.4683 C37H68NO8P PE(14:1/18:2)
  1. Compared with control group. LPC lysophosphatidylcholines, PC phosphatidylcholine, TG triacylglycerols, LPE hemolytic cephalin